Aptevo Therapeutics - Stock Price History | APVO

Historical daily share price chart and data for Aptevo Therapeutics since 2021 adjusted for splits. The latest closing stock price for Aptevo Therapeutics as of September 24, 2021 is 16.75.
  • The all-time high Aptevo Therapeutics stock closing price was 112.04 on July 20, 2016.
  • The Aptevo Therapeutics 52-week high stock price is 60.00, which is 258.2% above the current share price.
  • The Aptevo Therapeutics 52-week low stock price is 6.17, which is 63.2% below the current share price.
  • The average Aptevo Therapeutics stock price for the last 52 weeks is 26.26.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Aptevo Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 12.0499 9.0028 48.3600 3.1100 36.6500 299.82%
2019 12.4880 19.8880 26.1905 7.3669 9.1667 -48.46%
2018 56.7814 66.5266 83.1933 17.3669 17.7871 -70.05%
2017 31.7020 35.0140 59.6639 16.6667 59.3838 73.77%
2016 37.7116 112.0448 112.0448 25.6303 34.1737 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.083B $0.004B
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71